Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPATC1L | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
mRNA | PNISR | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
mRNA | KRTAP4-2 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |
mRNA | ICE2 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
mRNA | MFSD2B | CTRPv2 | pan-cancer | AAC | 0.22 | 0.04 |
mRNA | SHANK1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.04 |
mRNA | TGOLN2 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.04 |
mRNA | TCEB2 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.04 |
mRNA | CNTFR | CTRPv2 | pan-cancer | AAC | 0.6 | 0.04 |
mRNA | TAF1D | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |